Sponsor:
University of North Carolina, Chapel Hill
Code:
NCT07756359
Conditions
Pouch, Ileal
Pouches, Ileoanal
Bowel Diseases, Inflammatory
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
Tirzepatide
Loperamide
Diphenoxylate/Atropine
Brief summary:
Conditions
Pouch, Ileal
Pouches, Ileoanal
Bowel Diseases, Inflammatory
Study ID
NCT07756359
Start date
Jan 4, 2027
Status verified date
Nov, 2026
Completion date
Sep, 2027
Anticipated
Primary completion date
Sep, 2027
Anticipated
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Enrollment
20 participants
Anticipated
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary purpose
Treatment
Arms
experimental: Tirzepatide
active comparator: Optimized Standard of Care anti-diarrheal therapy
Interventions
Tirzepatide
Loperamide
Diphenoxylate/Atropine
Primary outcome measure
Central contacts
Locations
University of North Carolina
Recruiting
Chapel Hill, North Carolina, United States, 27599
Contacts
Principal Investigator:
Edward Barnes, MD, MPH
Sponsor
University of North Carolina, Chapel Hill
Last update posted
Nov 18, 2026
Last verified
Nov, 2026
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-11-19. This information was provided to ClinicalTrials.gov by University of North Carolina, Chapel Hill on 2026-11-18. Recruitment status is synced daily from ClinicalTrials.gov and may not reflect the sponsor's current status. Confirm during your call.